Homoeriodictyol 7-O-glucoside structure
|
Common Name | Homoeriodictyol 7-O-glucoside | ||
---|---|---|---|---|
CAS Number | 14982-11-7 | Molecular Weight | 464.41900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H24O11 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Homoeriodictyol 7-O-glucosideHomoeriodictyol 7-O-β-D-glucoside is a natural platelet-activating factor (PAF) antagonist. Homoeriodictyol 7-O-β-D-glucoside inhibits human and rabbit platelet aggregation induced by PAF, with an IC50 of 0.8 μM[1]. |
Name | homoeriodictyol-7-O-β-Glc |
---|---|
Synonym | More Synonyms |
Description | Homoeriodictyol 7-O-β-D-glucoside is a natural platelet-activating factor (PAF) antagonist. Homoeriodictyol 7-O-β-D-glucoside inhibits human and rabbit platelet aggregation induced by PAF, with an IC50 of 0.8 μM[1]. |
---|---|
Related Catalog | |
Target |
platelet-activating factor[1] |
In Vitro | Homoeriodictyol 7-O-β-D-glucoside significantly inhibits human and rabbit platelet aggregation induced by PAF, but has no inhibitory effect on platelet aggregation induced by Adenosine diphosphate (ADP)[1]. |
References |
Molecular Formula | C22H24O11 |
---|---|
Molecular Weight | 464.41900 |
Exact Mass | 464.13200 |
PSA | 175.37000 |
Hedt-II |
5-Hydroxy-2-(4-hydroxy-3-methoxy-phenyl)-7-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chroman-4-one |
Homoeriodictyol-7-glucosid |
homoeriodictyol-7-O-β-D-glucopyranoside |